🚀 Pharmidex In Silico Drug Discovery – The Complete Pipeline! 🧬💻

February 28, 2025

At Pharmidex, we bring cutting-edge computational, structural, and molecular biology expertise to accelerate drug discovery and development. Whether you know your protein target and need to find a drug or have drug candidates and need to identify their target, our comprehensive in silico pipeline ensures success.

✨ Why Choose Pharmidex?
✅ Gold-standard software for precision modeling
✅ Hit and binding site identification for target validation
✅ Library mining, extraction, and de novo design
✅ 2D & 3D ligand-based modeling for enhanced screening
✅ Pathway exploration and molecular dynamics analysis
✅ X-ray crystallography & Cryo-EM structure refinement

From target determination to lead optimization, we streamline your drug discovery journey with advanced AI-driven solutions and deep scientific expertise.

📽️ Watch our latest video (5/5) showcasing how Pharmidex transforms drug discovery through computational innovation!

📩 Let’s collaborate and push the boundaries of pharmaceutical innovation together!

#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

< Older Post

Newer Post >

Thanks to our interns from City St George’s, University of London

June 19, 2026

A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.

Pharmidex at the "Creative Disruption Forum: Modern Drug Discovery in Cambridge."

June 17, 2026

On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. 📅 18 June 2025 📍 Cambridge 🕒 Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.

Congratulate Dr Mansoor Chishty as Director of DMPK at Pharmidex

June 16, 2026

This well-deserved appointment marks an important milestone in a remarkable career spanning more than 22 years at Pharmidex . Over the years, Dr Chishty has made a significant contribution to the growth of our DMPK capabilities, applying his extensive expertise in Drug Metabolism and Pharmacokinetics to support successful drug discovery and development programmes for clients worldwide. His scientific leadership, dedication and commitment to excellence have been instrumental in strengthening our services and supporting the continued success of Pharmidex . As we continue to grow and support innovative biopharmaceutical companies, we look forward to the impact Dr Chishty will make in this new role. Please join us in congratulating Dr Mansoor Chishty on this achievement and wishing him every success as Director of DMPK.